BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edvardsen K, Bjånesøy T, Hellesen A, Breivik L, Bakke M, Husebye ES, Bratland E. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. J Interferon Cytokine Res 2015;35:759-70. [PMID: 25978633 DOI: 10.1089/jir.2014.0171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Fitzpatrick JM, Hackett B, Costelloe L, Hind W, Downer EJ. Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules 2022;27:1763. [PMID: 35335126 DOI: 10.3390/molecules27061763] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, Giagulli VA, Guastamacchia E, De Pergola G, Vacca A, Racanelli V, Triggiani V. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med 2021;10:2920. [PMID: 34209964 DOI: 10.3390/jcm10132920] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
3 Batten I, Robinson MW, White A, Walsh C, Fazekas B, Wyse J, Buettner A, D'Arcy S, Greenan E, Murphy CC, Wigston Z, Gabhann-Dromgoole JN, Vital EM, Little MA, Bourke NM. Investigation of type I interferon responses in ANCA-associated vasculitis. Sci Rep 2021;11:8272. [PMID: 33859290 DOI: 10.1038/s41598-021-87760-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fallahi P, Ferrari SM, Ragusa F, Ruffilli I, Elia G, Paparo SR, Antonelli A. Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab 2020;105:dgz289. [PMID: 31863667 DOI: 10.1210/clinem/dgz289] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
5 Magnusson L, Espes D, Casas R, Carlsson PO. Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases. Front Immunol 2020;11:1916. [PMID: 32983115 DOI: 10.3389/fimmu.2020.01916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rhee EJ, Kim JH, Moon SJ, Lee WY. Encountering COVID-19 as Endocrinologists. Endocrinol Metab (Seoul) 2020;35:197-205. [PMID: 32372573 DOI: 10.3803/EnM.2020.35.2.197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
7 Bentley C, Hazeldine J, Greig C, Lord J, Foster M. Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient. Burns Trauma 2019;7:26. [PMID: 31388512 DOI: 10.1186/s41038-019-0158-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
8 Aslaksen S, Wolff AB, Vigeland MD, Breivik L, Sheng Y, Oftedal BE, Artaza H, Skinningsrud B, Undlien DE, Selmer KK, Husebye ES, Bratland E. Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease. J Transl Autoimmun 2019;1:100005. [PMID: 32743495 DOI: 10.1016/j.jtauto.2019.100005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Hellesen A, Bratland E. The potential role for infections in the pathogenesis of autoimmune Addison's disease. Clin Exp Immunol 2019;195:52-63. [PMID: 30144040 DOI: 10.1111/cei.13207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Throm AA, Moncrieffe H, Orandi AB, Pingel JT, Geurs TL, Miller HL, Daugherty AL, Malkova ON, Lovell DJ, Thompson SD, Grom AA, Cooper MA, Oh ST, French AR. Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry. JCI Insight 2018;3:121544. [PMID: 30089725 DOI: 10.1172/jci.insight.121544] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
11 Hellesen A, Bratland E, Husebye ES. Autoimmune Addison's disease - An update on pathogenesis. Ann Endocrinol (Paris) 2018;79:157-63. [PMID: 29631795 DOI: 10.1016/j.ando.2018.03.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
12 Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM, Arlt W. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol 2017;176:471-80. [PMID: 28223394 DOI: 10.1530/EJE-16-0969] [Cited by in Crossref: 55] [Cited by in F6Publishing: 62] [Article Influence: 9.2] [Reference Citation Analysis]
13 Xu Z, Zhang X, Lau J, Yu J. C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. Expert Rev Mol Med 2016;18:e16. [PMID: 27669973 DOI: 10.1017/erm.2016.16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
14 Edvardsen K, Hellesen A, Husebye ES, Bratland E. Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. J Transl Med 2016;14:68. [PMID: 26956521 DOI: 10.1186/s12967-016-0822-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]